Erythromycin-felodipine interaction: Magnitude, mechanism, and comparison with grapefruit juice

Clinical Pharmacology and Therapeutics

Volumn 60, Issue 1, 1996, Pages 25-33

  Bailey, David G ^a,b   Bend, John R ^a   Arnold, J Malcolm O ^a   Tran, Lan T ^a   Spence, J David ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b LONDON HEALTH SCIENCES CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

4 (2,3 DICHLOROPHENYL) 2,6 DIMETHYL 3,5 PYRIDINEDICARBOXYLIC ACID ETHYL METHYL ESTER; DRUG METABOLITE; ERYTHROMYCIN; FELODIPINE;

AREA UNDER THE CURVE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG BLOOD LEVEL; DRUG ELIMINATION; DRUG HALF LIFE; DRUG METABOLISM; FOOD DRUG INTERACTION; FRUIT JUICE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SUSTAINED RELEASE PREPARATION;

EID: 0029782647     PISSN: 00099236     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-9236(96)90163-0     Document Type: Article

References (29)

1. Liedholm H, Nordin G. Erythromycin-felodipine interaction. Drug Intell Clin Pharm 1991;25:1007-8.
2. Edgar B, Regårdh CG, Johnsson G, Johansson L, Lundborg P, Löfberg I, et al. Felodipine kinetics in healthy men. Clin Pharmacol Ther 1985;38:205-11.
3. Regårdh CG, Bäärnhielm C, Edgar B, Hoffmann KJ. Pharmacokinetics and biotransformation of 1,4-dihydropyridine calcium channel antagonists. Prog Drug Metab 1990;12:41-86.
4. Guengerich FP, Brian WP, Iwasaki M, Sari MA, Bäärnhielm C, Berntsson P. Oxidation of dihydropyridine calcium channel blockers and analogues by human liver cytochrome P450IIIA4. J Med Chem 1991;34:1838-44.
5. Guengerich FP. Catalytic selectivity of human cytochrome P450 enzymes: relevance to drug metabolism and toxicity. Toxicol Lett 1994;70:133-8.
6. Nishioka R, Umeda I, Oi N, Tabata S, Uno K. Determination of felodipine and its metabolites in plasma using capillary gas chromatography with electron-capture detection and their identification by gas chromatography-mass spectrometry. J Chromatogr 1991;565:237-46.
7. Watkins PB, Murray SA, Winkelman LG, Heuman DM, Wrighton SA, Guzelian PS. Erythromycin breath test as an assay of glucocorticoid-inducible liver cytochromes P-450. J Clin Invest 1989;83:688-97.
8. Olkkola KT, Aranko K, Luurila H, Hiller A, Saarnivaara L, Himberg JJ, et al. A potentially hazardous interaction between erythromycin and midazolam. Clin Pharmacol Ther 1993;53:298-305.
9. Honig PK, Woosley RL, Zamani K, Conner DP, Cantilena LR. Changes in the pharmacokinetics and electrocardiographic pharmacodynamics of terfenadine with concomitant administration of erythromycin. Clin Pharmacol Ther 1992;52:231-8.
10. Bailey DG, Spence JD, Munoz C, Arnold JMO. Interaction of citrus juices with felodipine and nifedipine. Lancet 1991;337:268-9.
11. Edgar B, Bailey DG, Bergstrand R, Johnsson G, Regårdh CG. Acute effect of drinking grapefruit juice on the pharmacokinetics and dynamics of felodipine-and its potential clinical relevance. Eur J Clin Pharmacol 1992;42:313-7.
12. Bailey DG, Arnold JMO, Munoz C, Spence JD. Grapefruit juice-felodipine interaction: mechanism, predictability and effect of naringin. Clin Pharmacol Ther 1993;53:637-42.
13. Bailey DG, Arnold JMO, Spence JD. Grapefruit juice and drugs: how significant is the interaction? Clin Pharmacokinet 1994;26:91-8.
14. Bailey DG, Arnold JMO, Bend JR, Tran LT, Spence JD. Grapefruit juice-felodipine interaction: reproducibility and characterization with the extended release drug formulation. Br J Clin Pharmacol 1995;40:135-40.
15. Ahnoff M. Determination of felodipine in plasma by capillary gas chromatography with electron capture detection. J Pharm Biomed Anal 1984;2:519-26.
16. Gabrielsson M, Hoffmann KJ, Regårdh CG. Determination of four carboxylic acid metabolites of felodipine in plasma by high performance liquid chromatography. J Chromatogr 1992;573:265-74.
17. Brun J, Froberg L, Kronmann P, Olsson LB, Skoog P, Tygesen G, et al. Optimal felodipine dose when combined with metoprolol in arterial hypertension: a Swedish multicentre study with primary health care. J Cardiovasc Pharmacol 1990;15(suppl 4):S60-4.
18. Regårdh CG, Edgar B, Olsson R, Kendall M, Collste P, Shansky C. Pharmacokinetics of felodipine in patients with liver disease. Eur J Clin Pharmacol 1989; 36:473-9.
19. Wang SX, Sutfin TA, Baarnhielm C, Regårdh CG. Contribution of the intestine to the first-pass metabolism of felodipine in the rat. J Pharmacol Exp Ther 1989;250:632-6.
20. Waller DG, Renwick AG, Gruchy BS, George CF. The first pass metabolism of nifedipine in man. Br J Clin Pharmacol 1984;18:951-4.
21. Kolars JC, Awni WM, Merion RM, Watkins PB. First-pass metabolism of cyclosporin by the gut. Lancet 1991;338:1488-90.
22. Guengerich FP. Characterization of human cytochrome P450 enzymes. FASEB J 1992;6:745-8.
23. Shimada T, Yamazaki H, Mimura M, Inui Y, Guengerich FP. Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians. J Pharmacol Exp Ther 1994;270:414-23.
24. Kolars JC, Schmiedlin-Ren P, Schuetz JD, Fang C, Watkins PB. Identification of rifampin-inducible P450IIIA4 (CYP3A4) in human small bowel enterocytes. J Clin Invest 1992;90:1871-8.
25. Lown KS, Kolars JC, Thummel KE, Barnett JL, Kunze KL, Wrighton SA, et al. Interpatient heterogeneity in expression of CYP3A4 and CYP3A5 in small bowel - lack of prediction by the erythromycin breath test. Drug Metab Dispos 1994;22:947-55.
26. Rashid TJ, Martin U, Clarke H, Waller DG, Renwick AG, George CF. Factors effecting the absolute bioavailability of nifedipine. Br J Clin Pharmacol 1995; 40:51-8.
27. Ducharme MP, Warbasse LH, Edwards DJ. Disposition of intravenous and oral cyclosporine after administration with grapefruit juice. Clin Pharmacol Ther 1995;57:485-91.
28. Kupferschmidt HHT, Ha HR, Ziegler WH, Meir PJ, Krahenbuhl S. Interaction between grapefruit juice and midazolam in humans. Clin Pharmacol Ther 1995;58:20-8.
29. Hukkinen SK, Varhe A, Olkkola KT, Neuvonen PJ. Plasma concentrations of triazolam are increased by concomitant ingestion of grapefruit juice. Clin Pharmacol Ther 1995;58:127-31.